INTELLIA THERAPEUTICS INC (NTLA)

US45826J1051 - Common Stock

24.02  +0.75 (+3.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
36.27M52.12M33.05M57.99M43.10M
Operating Expenses
551.57M510.29M300.90M194.58M149.47M
Research and Development
435.07M419.98M229.81M150.41M108.41M
Selling, General, and Administrative Expenses
116.50M90.31M71.10M44.17M41.06M
Operating Income
-515.29M-458.16M-267.85M-136.58M-106.37M
Interest Income/Expense
34.20M-2.54M-40.00K2.35M6.84M
Other Income/Expense
-100.00K-13.49MN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-481.19M-474.19M-267.89M-134.23M-99.53M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-481.19M-474.19M-267.89M-134.23M-99.53M
EBITDA
-506.32M-450.59M-260.96M-130.27M-100.78M
 
Per Share Data
EPS Diluted Total Ops
-5.42-6.16-3.78-2.40-2.11
Non GAAP EPS
-5.41-6.18-3.76-2.40-2.11
 
Statistics
Profit Margin
-1326.51%-909.80%-810.56%-231.47%-230.93%
Operating Profit Margin
-1420.51%-879.05%-810.44%-235.52%-246.80%

All data in USD

Charts